InflaRx (IFRX) Preferred Shares (2016 - 2017)

InflaRx's (IFRX) quarterly Preferred Shares came in at $67.5 million in Q3 2017, up 16.95% quarter-over-quarter from $57.7 million in Q4 2016.

InflaRx (IFRX) Preferred Shares (2016 - 2017) Analysis & Trends

InflaRx has disclosed Preferred Shares across 2 years of filings, most recently posting $67.5 million for Q3 2017.

Preferred Shares for Q3 2017 came in at $67.5 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2017 was $67.5 million (changed N/A YoY), and the FY2016 annual result was $59.2 million, changed N/A from the prior year.
Preferred Shares came in at $67.5 million for Q3 2017 at InflaRx, up from $57.7 million in the prior quarter.
In the past five years, Preferred Shares ranged from a high of $67.5 million in Q3 2017 to a low of $57.7 million in Q4 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	InflaRx	752.21 Mn	752.21 Mn	10,877.40	-

Download Data

Date	Value
Sep 30, 2017	67.48 Mn
Dec 31, 2016	57.70 Mn